Hello every bio-field expert, professor, researcher:

Our experiment design aims to induce the immune system, to affect the tumor cell progress. In the previous study, we found a connection between programmed death proteins and the immune system, our final goal was to combine them with monoclonal antibodies or adoptive T-cell therapy.

This time, we're planning to knock out a "key gene" to do the experiment, if this cell is not that sensitive to induce Immunogenic, our effectiveness would be lower than expected.

Hopefully, can get your help, thanks for your reading.

More Ya Hui Zhang's questions See All
Similar questions and discussions